UNAUDITED FINANCIAL RESULTS  - STAND ALONE
FOR THE QUARTER  ENDED 30th SEPTEMBER, 2009
Rs. Lakhs
Sl  No. Particulars 3 months      ended              30th Sept, 2009 Corresponding          3 months ended in the previous year           30th Sept, 2008 Year to date figures for current half year ended            30th Sept, 2009 Year to    date    figures    for    previous    year ended                      30th Sept, 2008  Previous accounting period 9 months ended  31st March, 2009 
     Unaudited  Unaudited  Unaudited  Unaudited Audited 
1 Net sales / Income from Operations             9,643.75                 8,144.60           18,380.49                  14,315.30                      25,387.36
2 Expenditure          
  a) (Increase)/decrease in finished goods          
           and work in progress               (272.28)                  (517.09)              (341.45)                     (794.04)                          (134.33)
  b) Consumption of Raw Materials             6,174.29                 5,685.69           11,722.02                    9,661.90                      15,713.29
  c) Employee cost                554.05                   405.47             1,099.94                      772.87                        1,396.71
  d) Depreciation                392.57                   259.84               783.60                      509.90                           974.79
  e) Manufacturing Expenses                660.09                   477.86             1,213.65                      888.73                        1,590.85
  f) Administrative Expenses                331.36                   253.91               643.65                      469.31                           934.56
  g) Selling & Distribution Expenses                611.19                   491.29             1,235.24                      924.72                        1,566.81
  h) R &  D Expenses                106.04                   106.19               170.49                      148.11                           278.44
  i) Other expenditure                  17.38                       9.40                 31.62                        19.00                            21.79
        Total             8,574.71                 7,172.55           16,558.76                  12,600.50                      22,342.91
3 Profit from Operations before Other Income, Interest & Exceptional Items (1-2)             1,069.05                   972.05             1,821.73                    1,714.80                        3,044.46
4 Other Income                  (6.54)                    (19.09)                (14.69)                       (30.00)                           (85.47)
5 Profit before Interest and Exceptional Items             1,075.58                   991.14             1,836.42                    1,744.80                        3,129.92
6 Interest and Finance charges                374.46                   391.07               865.25                      726.62                        1,453.83
7 Profit after Interest but before exceptional items                701.13                   600.07               971.17                    1,018.19                        1,676.09
8 Foreign Exchange Fluctuations (gain)/loss                 (40.89)                   245.72              (508.55)                      320.22                           890.41
9 Profit before taxation                742.02                   354.35             1,479.72                      697.96                           785.68
10  Tax expense           
           - Current Tax Expense                  126.11                     40.15               251.48                        79.25                            89.02
           - Deferred Tax Expense                    9.24                     36.79                   1.72                        67.77                           180.25
            Fringe Benefit Tax                        -                         3.23                      -                            6.49                              7.88
11  Net Profit for the period                 606.67                   274.19             1,226.53                      544.46                           508.53
12  Paid-up share capital              2,005.72                 2,005.72             2,005.72                    2,005.72                        2,005.72
      (Face Value of Rs.10/- each)          
13 Reserves excluding Revaluation Reserve                       -                            -                            16,109.41
14 Basic Earnings per share (Rs.)*                   3.02                       1.37                   6.12                          2.71                              2.54
15 Basic Earnings per share (Annualised) (Rs.)*                       -                            -                                    3.39
15 Diluted Earnings per share (Rs.)*  -                        1.25                                     -  
15 Public Shareholding          
    - No. of shares          12,579,271             12,644,517         12,579,271                12,644,517                    12,620,942
    - Percentage of shareholding 62.72% 63.04% 62.72% 63.04% 62.92%
16 Promoters and promoter group          
  Shareholding          
  a) Pledged/Encumbered          
       Number of shares           1,623,000                          -             1,623,000                        1,522,650
      Percentage of shares to promoter group 23.50%                          -   23.50%   22.19%
      Percentage of shares to total capital  8.09%                          -   8.09%   7.59%
  b) Non-encumbered          
       Number of shares           5,281,843                          -             5,281,843                        5,340,522
      Percentage of shares to promoter group 76.49%                          -   76.49%   77.81%
      Percentage of shares to total capital  26.33%                          -   26.33%   26.62%
* Not Annualised 
1) The above  results were reviewed by the Audit Committee and approved by the Board at its meeting  held on 26th October, 2009 
    and were subjected to limited review by Statutory Auditors.
2) Foreign Exchange Fluctuations (gain) of Rs.40.89 lakhs (net) for the quarter includes re-statement of foreign currency loans, receivables and payables. As per
    the amendment dated 31-3-2009 to Companies (Accounting Standards) Rules 2006,  the enterprise  is given the option either to continue  with the provisions of
    Accounting Standard 11 - The Effects of Changes in Foreign Exchange Rates or capitalise exchange differences (gain/(loss)) arising on reporting of long term foreign
     currency monetary items so far as they relate to the acquisition of a depreciable capital asset.  The Company has opted to continue with the existing practice of
    recognising the exchange differences on long term  foreign currency monetary items in the Profit and Loss Account.
3) The company has received 20 complaints from investors during the quarter 1st July '09 to 30th September, 2009 and all were resolved. No complaints were pending
    from previous quarter.
4) The Company operates only in the segment of Pharmaceuticals.
5) Figures are regrouped wherever necessary.
 for and on behalf of the Board 
Place  : Hyderabad        Dr.C.Nageswara Rao 
Date   :  26.10.2009                Chairman 
GRANULES INDIA LIMITED
Regd Office : 2nd Floor, 3rd Block, My Home Hub
Madhapur, Hyderabad 500 081
GRANULES INDIA LIMITED
Regd Office : 2nd Floor, 3rd Block, My Home Hub
Madhapur, Hyderabad 500 081
UNAUDITED FINANCIAL RESULTS - CONSOLIDATED
FOR THE QUARTER  ENDED 30th SEPTEMBER, 2009
Rs. Lakhs
Sl  No. Particulars 3 months ended              30th Sept, 2009 Year to date figures for current half year ended            30th Sept, 2009  Previous accounting period 9 months ended  31st March, 2009 
     Unaudited  Unaudited Audited 
1 Net sales / Income from Operations                     11,455.12             22,047.04                 28,927.48
2 Expenditure      
  a) (Increase)/decrease in finished goods      
           and work in progress                             2.47                  206.88                     219.60
  b) Consumption of Raw Materials                       6,911.77             13,267.75                 17,427.66
  c) Employee cost                         685.67               1,356.13                  1,756.87
  d) Depreciation                         459.12                  919.05                  1,179.98
  e) Manufacturing Expenses                         923.62               1,697.02                  1,986.67
  f) Administrative Expenses                         382.73                  753.09                  1,103.68
  g) Selling & Distribution Expenses                         706.78               1,338.03                  1,850.12
  h) R &  D Expenses                         106.04                  173.37                     287.72
  i) Other expenditure                           17.67                   31.91                       21.79
        Total                     10,195.88             19,743.24                 25,834.09
3 Profit from Operations before Other Income, Interest & Exceptional Items (1-2)                       1,259.25               2,303.81                  3,093.39
4 Other Income                          (22.38)                  (36.51)                    (100.29)
5 Profit before Interest and Exceptional Items                       1,281.63               2,340.32                  3,193.68
6 Interest and Finance charges                         402.75                  922.33                  1,567.58
7 Profit after Interest but before exceptional items                         878.88               1,417.99                  1,626.11
8 Foreign Exchange Fluctuations (gain)/loss                          (38.96)                 (504.15)                     924.05
9 Profit before taxation                         917.83               1,922.14                     702.06
10  Tax expense       
            Current Tax Expense                           133.74                  285.30                       89.29
            Deferred Tax Expense                              9.24                     1.72                     180.25
            Fringe Benefit Tax                                 -                          -                           7.88
11  Net Profit for the period                          774.86               1,635.12                     424.65
12  Paid-up share capital                        2,005.72               2,005.72                  2,005.72
      (Face Value of Rs.10/- each)      
13 Reserves excluding Revaluation Reserve                                -                          -                   15,319.92
14 Basic Earnings per share (Rs.)*                             3.86                     8.15                         2.08
15 Public Shareholding      
    - No. of shares                   12,579,271           12,579,271               12,620,942
    - Percentage of shareholding 62.72% 62.72% 62.92%
16 Promoters and promoter group      
  Shareholding      
  a) Pledged/Encumbered      
       Number of shares                     1,623,000             1,623,000                 1,522,650
      Percentage of shares to promoter group 23.50% 23.50% 22.19%
      Percentage of shares to total capital  8.09% 8.09% 7.59%
  b) Non-encumbered      
       Number of shares                     5,281,843             5,281,843                 5,340,522
      Percentage of shares to promoter group 76.49% 76.49% 77.81%
      Percentage of shares to total capital  26.33% 26.33% 26.62%
* Not Annualised
NOTES :
1) The above  results were reviewed by the Audit Committee and approved by the Board at its meeting  held on 26th October, 2009 
    and were subjected to limited review by Statutory Auditors.
2) Foreign Exchange Fluctuations (gain) of Rs.38.96 lakhs (net) for the quarter includes re-statement of foreign currency loans,
    receivables and payables. As per the amendment dated 31-3-2009 to Companies (Accounting Standards) Rules 2006,  the enterprise
    is given the option either to continue  with the provisions of Accounting Standard 11 - The Effects of Changes in Foreign Exchange
    Rates or capitalise exchange differences (gain/(loss)) arising on reporting of long term foreign currency monetary items so far as they
    relate to the acquisition of a depreciable capital asset.  The Company has opted to continue with the existing practice of recognising
    the exchange differences on long term  foreign currency monetary items in the Profit and Loss Account.
3) The company has received 20 complaints from investors during the quarter 1st July '09 to 30th September, 2009 and all were resolved.
     No complaints were pending from previous quarter.
4) The Company operates only in the segment of Pharmaceuticals.
5) The Company has been stating its consolidated results from the Quarter ending December, 2008.  Hence figures for the corresponding
     period of previous year are not given.
6) Figures are regrouped wherever necessary.
 for and on behalf of the Board 
Place  : Hyderabad        Dr.C.Nageswara Rao 
Date   :  26.10.2009                Chairman